NCT03666988 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID	NCT03666988
Title	First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL)
Recruitment	Terminated
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	GlaxoSmithKline
Indications	ureter transitional cell carcinoma bladder urothelial carcinoma renal pelvis transitional cell carcinoma urethra transitional cell carcinoma pancreatic adenocarcinoma Advanced Solid Tumor relapsed/refractory diffuse large B-cell lymphoma lung non-small cell carcinoma
Therapies	GSK3368715
Age Groups:	senior \| adult
Covered Countries	USA \| ESP \| CAN \| AUS

Additional content available in CKB BOOST